parallel randomized trial

S002995

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Type 2 diabetes (adults)S002995

Design

Randomized: 24
Start year
Treatment: 12 weeks
Countries
Sponsor: (not reported)
Eligibility: obese type 2 diabetes on oral agents with insulin

Conduct and analysis

Blinding: not reported
Sequence generation: not reported
Allocation concealment: not reported
Outcome adjudication: not reported
Primary estimand: not stated
Analysis population
Missing data

Arms

Arm	Treatment	Background	Randomized	Analyzed	Completed treatment
A1	liraglutide Liraglutide maximum tolerated dose	oral glucose lowering agents with insulin; lifestyle: not reported	12
A2	Standard care or no added treatment Standard therapy	oral glucose lowering agents with insulin; lifestyle: not reported	12

Results

2 adjudicated result lines, grouped by outcome. Open an outcome to see its values.

HbA1c change (2 lines; O01)

Week	Arm	Statistic	Estimate	SE or SD	95% CI	Events / N	Detail
12	A1	change	percent			12	not stated; other; R0008225:Abstract
12	A2	change	percent			12	not stated; other; R0008225:Abstract